Search Results 3061-3070 of 126103 for Cycle

1. ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Intravenous Amikacin Treatment of Non-Tuberculous Mycobacterium Disease - Mayo Clinic

   ... cycle) following the last dose of study drug, or agree to practice true abstinence. Exclusion Criteria: Received a systemic aminoglycoside antibiotic within ...

2. DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma - Mayo Clinic

   ... cycle); patient can be treated with bevacizumab alone or in combination with other chemotherapies. Participating Mayo Clinic locations. Study statuses change ...

3. Alcohol use disorder - Diagnosis and treatment - Mayo Clinic

   Unhealthy alcohol use ranges from mild to severe, including alcoholism and binge drinking, putting health and safety at risk. Early treatment is important.

4. Amyloidosis - Doctors and departments - Mayo Clinic

   So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes ...

5. Fibromyalgia - Doctors and departments - Mayo Clinic

   So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes ...

6. Angiosarcoma - Doctors and departments - Mayo Clinic

   So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes ...

7. Movement disorders - Doctors and departments - Mayo Clinic

   So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes ...

8. Movement disorders - Doctors and departments - Mayo Clinic

   So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes ...

9. Sarcoma - Doctors and departments - Mayo Clinic

   So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes ...

10. A Study of FT 2102 in Participants with Advanced Solid Tumors and Gliomas with an IDH1 Mutation - Mayo Clinic

    Combination Phase 2 (beyond Safety Lead-in): have received no more than 1 cycle of gemcitabine/cisplatin therapy. Other solid tumors that have relapsed or ...